Back
Doximity, Inc. Vs. Stoke Therapeutics, Inc. Industry Stock Comparison
Sell
26
DOCS
Doximity, Inc.
Last Price:
$44.12
Seasonality Move:
0.03%
Buy
66
STOK
Stoke Therapeutics, Inc.
Last Price:
$33.08
Seasonality Move:
1.4%
Sell
26
Doximity, Inc. (DOCS)
is a Sell
Is Doximity, Inc. a Buy, Sell or Hold?
-
The current Doximity, Inc. [DOCS] share price is $44.13. The Score for DOCS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
DOCS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Stoke Therapeutics, Inc. [STOK] share price is $33.09. The Score for STOK is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DOCS Stock Price Chart
What is Doximity, Inc.'s stock price today?
-
The Doximity, Inc. share price today is $44.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DOCS is experiencing selling pressure, which indicates risk of future bearish movement.
STOK Stock Price Chart
What is Stoke Therapeutics, Inc.'s stock price today?
-
The Stoke Therapeutics, Inc. share price today is $33.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.
DOCS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.65 | Sell |
| Relative Strength Index (14 RSI): | 25.19 | Sell |
| Chaikin Money Flow: | -2752217 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.07 - 53.57) | Sell |
| Bollinger Bands (100): | (54.09 - 71.53) | Sell |
STOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 60.05 | Buy |
| Chaikin Money Flow: | -924088 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.5 - 31.94) | Buy |
| Bollinger Bands (100): | (17.56 - 30.8) | Buy |
DOCS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.41 | Sell |
| 20-day SMA: | 48.62 | Sell |
| 50-day SMA: | 59 | Sell |
| 200-day SMA: | 60.61 | Sell |
| 8-day EMA: | 46.67 | Sell |
| 20-day EMA: | 49.83 | Sell |
| 50-day EMA: | 55.98 | Sell |
| 200-day EMA: | 58.69 | Sell |
STOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.68 | Buy |
| 20-day SMA: | 30 | Buy |
| 50-day SMA: | 29.59 | Buy |
| 200-day SMA: | 16.86 | Buy |
| 8-day EMA: | 31.92 | Buy |
| 20-day EMA: | 30.46 | Buy |
| 50-day EMA: | 28.38 | Buy |
| 200-day EMA: | 20.14 | Buy |
Doximity, Inc. Earnings Growth & DOCS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.26 per share.
Stoke Therapeutics, Inc. Earnings Growth & STOK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.
Doximity, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Stoke Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||